Tirzepatide, the newest weight loss drug in India, is transforming the wellness market with its hormone-mimicking effects.

The Subject Expert Committee (SEC) on Endocrinology and Metabolism, operating under the Central Drugs Standard Control ...

India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

A digital obesity clinic, Embla, is associated with 16.7% weight loss over 64 weeks, matching previous semaglutide trial ...

The benefit was seen as soon as 3 months. Investigators say there should be no delaying treatment for eligible patients.

New research being presented at the European Congress on Obesity (ECO 2025) has found that patients of an online obesity ...

New research being presented at this year's European Congress on Obesity (ECO 2025) has found that patients of an online obesity clinic achieved similar weight loss to that reported in clinical trials ...

Ozempic is a prescription drug used to deal with conditions related to high blood sugar levels and for diabetes management.

Oral semaglutide 14 mg was associated with better cardiometabolic outcomes than active comparators, including empaglifozin and liraglutide, among patients with T2D. Oral semaglutide improves ...